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That papillomaviruses can cause skin cancer has been
known for almost 70 years, after Peyton Rous and col-
leagues reported the malignant conversion of persistent
rabbit skin warts induced by the Shope cottontail rabbit
papillomavirus. The relationship between human papilloma-
viruses (HPV) and basal cell carcinoma (BCC) and squa-
mous cell carcinoma (SCC) of the skin is an important issue
since non-melanoma skin cancer (NMSC) is the most com-
mon form of malignancy among fair-skinned populations.
Moreover, immunosuppressed organ transplant recipients
are at high risk of developing NMSC, especially SCC. It
is well established that solar ultraviolet radiation (UVR) is
the major risk factor, acting through both mutagenic and
immunosuppressive effects. Cutaneous SCC, developing
in patients suffering from epidermodysplasia verruciformis
(EV), a rare genodermatosis associated with a high risk of
skin cancer, provided the evidence for a role of specific HPV
types in human cancer (reviewed in Orth, 1987). But the role
of HPV in premalignant lesions of the skin (actinic keratosis,
Bowen’s disease) and in NMSC in the general population
or upon immunosuppression is still a matter of debate (re-
viewed in Harwood and Proby, 2002; Pfister, 2003).
Before the advent of PCR technology, the Southern blot
hybridization technique was considered the gold standard
for the detection of HPV, and it allowed the identification of
most of the HPV genotypes fully characterized so far (over
90 types) (reviewed in Lowy and Howley, 2001). For skin
warts with a high virus content, HPV DNA could even be
identified by direct visualization of their restriction patterns
in ethidium bromide-stained gels. Preferential associations
were recognized between different clinical types of skin
warts and specific HPV genotypes (reviewed in Jablonska
et al, 1997). EV was found to result from an abnormal sus-
ceptibility to infection with a specific group of about 20 re-
lated HPV genotypes, known as EV HPV, as well as to the
oncogenic potential of a subset of these viruses. Infection
leads to the early development of persistent flat wart-like
and macular lesions. Upon their third or fourth decade,
about half of EV patients develop precancerous lesions and
SCC, mostly on sun-exposed areas of the skin. EV carci-
nomas were found to harbor high copy numbers of extra-
chromosomal HPV genomes (usually HPV5, occasionally
HPV8, 14, 17, 20, or 47) and abundant transcripts of the
viral E6 and E7 genes (Orth, 1987). This strongly suggests a
syncarcinogenic role of HPV5 (or related types) and UVR in
the early development of EV cancers. As for genital HPV,
specific types, such as HPV16 or HPV18, were detected in
over 80% of cervical carcinomas by Southern hybridization.
This paved the way for the demonstration of an etiological
role of these ‘‘high-risk’’ types in anogenital cancer (re-
viewed in zur Hausen 2002). But Southern hybridization,
sensitive enough to detect one copy of HPV genome per
cell, has seldom been successful in demonstrating HPV
sequences in premalignant and malignant lesions of the
skin of immunocompetent or immunosuppressed patients.
Notable exceptions are the rare HPV5-associated pheno-
copies of EV observed among immunosuppressed patients
and the uncommon HPV16-harboring periungual SCC
(Orth, 1987).
The development of a number of highly sensitive PCR
methods, based on various sets of degenerate primers de-
signed to detect a broad range of known or putative novel
HPV genotypes, has brought a wealth of information on the
epidemiology and the biology of HPV infections. These
approaches disclosed that cervical HPV infections are
widespread, often asymptomatic and transient, that HPV
infection precedes the development of cytological abnor-
malities, and that persistent infection with high-risk HPV is
the major risk factor for the development of cervical cancer.
DNA sequences of the genital high-risk HPV types were
detected in over 95% of cervical cancers. These virological
and epidemiological findings, as well as molecular data
demonstrating that the viral E6 and E7 oncoproteins play a
central role in tumor progression and maintenance of the
malignant phenotype, convincingly established the etiolog-
ical role of specific HPV in anogenital cancer (Lowy and
Howley, 2001; zur Hausen, 2002).
In contrast to the genital HPV genotypes, which belong
to the same phylogenetic group A, the cutaneous HPV show
a greater genetic heterogeneity (groups A, B1, B2, E) (Lowy
and Howley, 2001). Many different PCR approaches based
on degenerate primers have been used for the detection of
HPV sequences in premalignant and malignant lesions of
the skin as well as in healthy skin. Due to the distinct
specificities and sensitivities of the methods, the prevalence
and spectrum of the detected HPV showed some discrep-
ancy among studies (Harwood and Proby, 2002; Pfister,
2003). HPV DNA sequences were detected in a substantial
proportion of NMSC in immunocompetent individuals
(25%–55%) and in a still higher proportion of SCC (up to
90%) in organ transplant recipients. Similar HPV detection
Abbreviations: EV, epidermodysplasia verruciformis; HPV, human
papillomavirus; NMSC, nonmelanoma skin cancer; SCC, squa-
mous cell carcinoma; UVR, ultraviolet radiation
Copyright r 2004 by The Society for Investigative Dermatology, Inc.
xi
rates were found for premalignant skin lesions (Harwood
and Proby, 2002; Pfister, 2003). Unexpectedly, however,
high detection rates of HPV DNA were found also for healthy
skin biopsies, plucked hairs or skin swab samples in
immunocompetent and immunosuppressed individuals
(25%–65% and 30%–90% positive samples, respectively).
An impressive diversity of known HPV types or putative
novel types (over 100) belonging to groups B1 (EV HPV-
related types) or B2 (HPV4, 48, 50, 60, or 65 related types)
was identified by sequencing (Harwood and Proby, 2002;
Pfister, 2003). Thus, skin HPV represent ubiquitous viruses,
highly prevalent in the normal skin of healthy adults, and
causing asymptomatic infections likely to be acquired very
early in infancy. This may suggest a commensalic nature
(Antonsson et al, 2000; Forslund et al, 2004).
The high prevalence of HPV DNA in NMSC led research-
ers to reconsider the role of HPV in skin carcinogenesis.
Available data, however, are far from being conclusive. A
great diversity of HPV types, most frequently EV HPV
or putative novel EV HPV-related types, is detected, and
multiple infections are frequently observed, especially in
immunosuppressed patients. The tumor viral load is usually
low and HPV-negative and -positive tumors may coexist in
the same individual. No specific genotypes are significantly
associated with NMSC, arguing against the existence of
high-risk cutaneous HPV types in non-EV patients. More-
over, epidemiological and seroepidemiogical studies aimed
at establishing a link between cutaneous HPV infection and
NMSC are still in their infancy (Harwood and Proby, 2002;
Pfister, 2003).
The paper by Forslund and colleagues in this issue of the
Journal addresses the possibility that HPV positivity in
tumor biopsies may merely reflect contamination of the
surface of the tumors by viral DNA or particles harbored in
cells shed from infected healthy skin. The rationale was to
compare swab samples taken from seborrheic keratoses,
actinic keratoses, BCC and SCC of immunocompetent in-
dividuals, and biopsies from the same tumors after tape
stripping to remove the superficial layers. HPV DNA was
searched for by a PCR approach validated for the detection
of B1 and B2 HPV genotypes. The authors report that HPV
DNA is prevalent on top of the lesions but much less in the
stripped biopsies (58%–83% vs 8%–19% positive sam-
ples). The positivity of swabs taken from lesions was in the
same range as swabs from healthy skin. At least one HPV
type in common between stripped biopsies and swabs from
the same tumors was found only for 8% of the cases. That
viral particles may be present on the skin surface was sug-
gested by the detection of HPV DNA in swab samples neg-
ative for human DNA amplification. Indeed, the authors
report the observation of virions in a swab sample from
perilesional healthy skin of a patient with SCC. This very
important finding has to be confirmed in a large series of
HPV-positive individuals.
The findings reported by Forslund et al, raise interesting
questions on the biology of cutaneous HPV. The mecha-
nisms leading to persistent, asymptomatic infections remain
unknown. The virus would have to infect the slow-cycling,
self-renewing stem cells of the hair follicles or interfollicular
epidermis. Infection should be tightly controlled to ensure
normal epidermis homeostasis and to establish a co-
mmensalic state. This should involve interactions with the
microenvironment regulating stem cell renewal and the pro-
duction of transiently amplifying daughter cells committed
to terminal differentiation (Alonso and Fuchs, 2003). The
maintenance of the viral DNA as autonomous replicating
episomes at low copy numbers in the nuclei of dividing cells
would only require the expression of the viral E1 and E2
proteins (Lowy and Howley, 2001). The HPV life cycle is
intimately linked to the terminal differentiation process that
occurs in cells withdrawn from the cell cycle. To ensure
vegetative viral DNA replication and production of virions,
the host cellular replication machinery would have to be
turned on by the viral E6 and E7 oncoproteins. That such
productively infected epidermal proliferation units exist in
normal skin remains to be established, and this represents a
challenge for future research.
The data reported by Forslund et al, may shed some
doubts on the biological significance of HPV DNA detection
in NMSC of non-EV patients. This does not rule out that
HPV play a part in tumor initiation or promotion rather than
in the maintenance of the malignant state, especially in or-
gan transplant recipients (Harwood and Proby, 2002; Pfister,
2003). There is some experimental evidence that UVR ac-
tivates the transcription of the genome of certain cutaneous
HPV and that the E6 proteins of cutaneous genotypes exert
an antiapoptotic effect by promoting the degradation of the
proapoptotic Bak protein induced in keratinocytes by UVR.
This could favor the persistence of UVR-induced mutations
(reviewed in Storey (2002)). There is an obvious need for
adequate models to test whether the E6 and E7 genes ex-
pressed under the control of their own promoters can act
synergistically with UVR to transform keratinocytes in vivo.
Genetic factors are likely to be important in the interplay of
EV HPV and UVR. The recent demonstration that EV is
associated with mutations in either of two related genes
(EVER1, EVER2) encoding transmembrane proteins opens
new avenues to understand these interactions (Ramoz et al,
2002).
It has been postulated by Antonsson et al (2000) that,
due to coevolution with their host, some HPV have adapted
to spread among individuals without inducing any disease,
by causing chronic asymptomatic infections. This may be
the case for EV HPV genotypes. Benign epidermal hyper-
proliferation stimulates the expression of latent EV HPV, and
this could have beneficial (wound healing) or detrimental
(psoriasis) effects (Favre et al, 2000). Contribution of skin
HPV to the development of NMSC via a hit-and-run mech-
anism still has to be considered. Much remains to be
learned on the biology of cutaneous HPV and on their role in
the biology and pathology of the skin.
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